Non-invasive brain stimulation to improve language in people with Down syndrome.
Official title: Brain-directed Treatment to Improve Language in Adolescents and Young Adults With Down Syndrome: the Efficacy of Transcranial Direct Current Stimulation Coupled With Linguistic Training.
Run by Bambino Gesù Hospital and Research Institute · NCT07044804 · Data updated 2026-11-12
This project will test whether short sessions of transcranial direct current stimulation (tDCS) to the left frontal language area, combined with speech practice, can improve language in Italian-speaking adolescents and young adults with Down syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 21 Years |
| Sex | All |
| Enrollment | 36 (estimated) |
| Sponsor | Bambino Gesù Hospital and Research Institute Academic / other |
| Locations | 1 site (Rome) |
| Status | Recruiting |
| Started | January 27, 2025 |
| Main results expected | September 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT07044804 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Italian-speaking adolescents and young adults (12–21 years) with confirmed free trisomy 21, mental age ≥ 4 years, measurable speech intelligibility (ICS ≥ 3.5), and low scores on naming subtests.
✕Probably not a fit
Those with epilepsy, major psychiatric disorders, significant hearing or vision deficits, very low naming or imitation ability, or inability to attend repeated in-person visits are unlikely to receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This proof-of-concept, double-blind, placebo-controlled trial applies transcranial direct current stimulation (tDCS) to the left inferior frontal gyrus (IFG)—using either anodal or cathodal protocols—combined with speech-language practice to try to improve naming and intelligibility in adolescents and young adults with Down syndrome. Participants are Italian-speaking individuals aged 12–21 with confirmed free trisomy 21 and defined speech and mental-age eligibility; they receive active or sham stimulation over multiple in-person sessions at a single pediatric research center. Outcome measures focus on standardized naming subtests and caregiver-rated speech intelligibility along with short-term maintenance assessments. The trial compares clinical change after combined tDCS-plus-training versus sham-plus-training to determine whether stimulation adds benefit to behavioral therapy.
Why it matters
Potential benefit: If successful, participants could have improved naming and speech intelligibility that persist beyond the training sessions.
How similar studies have gone: Previous small trials combining tDCS with cognitive or language training have reported modest benefits in adults and some pediatric samples, but applying cathodal protocols specifically in Down syndrome is largely novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Italian speakers participants of both genders with the presence of a free trisomy 21 documented by karyotyping 2. Adolescents and young adults from 12 to 21 years old 3. Mental age ≥ 4 years (as assessed by Leiter-3 at baseline) 4. Scores \< 2 SD at the denomination subtest of BVL\_4-12 5. Be comprehensible to closest relatives, at least in part, exhibiting consistent speech sounds mesured by Intelligibility in Context Scale (ICS): Italian (McLeod, Harrison, \& McCormack, 2012) with a cut-off of 3.5 6. Informed consent/absent from each patient and Informed consent from their caregivers. Exclusion Criteria: 1. The presence of any neurosensory deficits, such as hypoacusis or serious visual impairments 2. The presence of epilepsy, familiarity with epilepsy and major psychopathological disorders 3. Scores \< 10 points at the denomination subtest of BVL\_4-12 4. Ability to verbally imitate less that 7 of 10 words during an imitation screening task 5. Undergoing concomitant speech therapy or psychopharmacological therapy for cognitive or behavioral improvement.
Where it's running
-
Bambino Gesù Children's Hospital, IRCCS
Rome, Italy Recruiting
Study contacts
- Study coordinator: Floriana Costanzo, PsyD, PhD
- Email: floriana.costanzo@opbg.net
- Phone: +390668597091
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Kinematic analysis of hand and arm movement in kids with Down syndrome, CP and healthy children
This study tests how well an instrumented Box and Block Test and motion tracking can measure upper-limb movement in healthy kids and those with pyramidal hemisyndrome or Down syndrome.
-
Sensory integration to help balance and movement in kids with Down syndrome
Aimed at seeing if adding sensory integration to physical therapy helps improve gross motor skills and balance in children with Down syndrome.
-
Collaboration for Down Syndrome Progress (CDP) in people with Down syndrome
A long-term study following people with Down syndrome of all ages to see how health and everyday life change over time.
-
JAK inhibitor treatment for Down syndrome in children and young adults
This study tests whether 6 months of tofacitinib can help improve safety and neurodevelopment in people with Down syndrome aged 6 to 22, compared with placebo.
-
Jump rope to improve navicular drop and foot posture in children with Down syndrome
This project will test whether adding jump-rope exercises to play activities helps improve foot posture in 4–15-year-old children with Down syndrome who have navicular drop.
-
Thymus removal and immune aging in people with Down syndrome
This study will try to see if removing part of the thymus affects immune health over time in people aged 1 and older with Down syndrome, comparing those who had thymectomy to those who did not and to unaffected household relatives.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.